Post-earnings recap
Reported
Thu, Nov 8, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
13%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Scholar Rock's earnings report shows a continued investment in research and development, which may appeal to long-term investors. The stock's slight increase of 0.12% suggests that investors are remaining optimistic despite the earnings miss. The lack of revenue data and guidance indicates uncertainty about short-term performance, but management's focus on their pipeline may provide some reassurance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.44 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Management remains focused on their long-term goals and the potential of their drug candidates. They acknowledged the challenges but emphasized their strategic direction.
Management highlighted ongoing research and development efforts.
They expressed commitment to advancing their pipeline despite current losses.